Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2764]

FDA grants accelerated approval to zongertinib for non-squamous NSCLC with HER2 TKD activating mutations

FDA grants accelerated approval to zongertinib for non-squamous NSCLC with HER2 TKD activating mutations

Unusual case of rare ovarian tumour mimicking pregnancy with successful treatment outcome

Unusual case of rare ovarian tumour mimicking pregnancy with successful treatment outcome

Research identifies promising new target for treating rare, aggressive childhood cancer

Research identifies promising new target for treating rare, aggressive childhood cancer

Study uncovers molecular “switch” behind chemoresistance in blood cancer

Study uncovers molecular “switch” behind chemoresistance in blood cancer

University identifies key protein in liver cancer resistance and develops inhibitor to enhance therapy and prevent cancer recurrence

University identifies key protein in liver cancer resistance and develops inhibitor to enhance therapy and prevent...

New treatment eliminates bladder cancer in 82% of patients

New treatment eliminates bladder cancer in 82% of patients

Dual immune checkpoint inhibition with radiotherapy does not improve progression-free survival for patients with newly diagnosed MGMT-unmethylated glioblastoma

Dual immune checkpoint inhibition with radiotherapy does not improve progression-free survival for patients with...

New compound disrupts survival pathways in aromatase inhibitor-resistant breast cancer cells

New compound disrupts survival pathways in aromatase inhibitor-resistant breast cancer cells

Zombie cancer cells give cold shoulder to chemotherapy

Zombie cancer cells give cold shoulder to chemotherapy

New cancer drug boosts effectiveness of chemotherapy – even in resistant tumours

New cancer drug boosts effectiveness of chemotherapy – even in resistant tumours

More from ecancer